ATI LPN
ATI LPN Med Surg Level 3 II Questions
Question 1 of 5
A nurse in a provider's office is reinforcing teaching with a client who has risk factors for atherosclerosis. The nurse should help the client identify which of the following as treatment goals?
Correct Answer: B
Rationale: Maintaining blood pressure below 140/90 mm Hg is a realistic goal to reduce vascular damage in atherosclerosis. Cholesterol should be <200 mg/dL, fat intake should be 25-35% of calories, and BMI should be in the healthy range (18.5-24.9).
Question 2 of 5
A nurse is checking the apical pulse of a client who is taking several cardiovascular medications. Which of the following actions should the nurse take?
Correct Answer: A
Rationale: Counting the apical pulse for a full minute ensures accuracy, especially with cardiovascular medications that may alter heart rate or rhythm.
Question 3 of 5
A nurse is preparing to administer digoxin 0.25 mg PO to a client. The amount available is digoxin 0.125 mg tablets. How many tablets should the nurse administer to the client? (Round to the nearest whole number. Use a leading zero if it applies. Do not use a trailing zero.)
Correct Answer: 2 tablets
Rationale: Prescribed dose (0.25 mg) divided by available dose (0.125 mg) equals 2 tablets.
Question 4 of 5
A nurse is giving a presentation to a community group about preventing atherosclerosis. Which of the following should the nurse include as a modifiable risk factor for this disorder? (Select all that apply.)
Correct Answer: A,B,D,E
Rationale: Smoking, obesity, hypertension, and hypercholesterolemia can be modified through lifestyle changes or medication, reducing atherosclerosis risk. Genetic predisposition is non-modifiable.
Question 5 of 5
A nurse is caring for a client who has hypertension and is to start taking atenolol (a betablocker) which also reduces the workload of the heart. The nurse should instruct the client to monitor for which of the following findings as an adverse effect of this medication?
Correct Answer: A
Rationale: Atenolol can cause bradycardia by slowing the heart rate, a key adverse effect to monitor.